Literature DB >> 12830567

Younger patients with type 2 diabetes need better glycaemic control: results of a community-based study describing factors associated with a high HbA1c value.

Dietrich Rothenbacher1, Gernot Rüter, Stefan Saam, Hermann Brenner.   

Abstract

This study of 845 patients with type 2 diabetes was conducted in 12 primary care general practices in a geographically cohesive region in Germany. It showed that about a fifth of these patients with known diabetes had a HbA1c of 8% or over, and therefore are in need of better glycaemic control. Younger patients seem to be at special risk for high HbA1c values, and they should receive particular attention with respect to preventive measures for better glycaemic treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12830567      PMCID: PMC1314599     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  4 in total

1.  Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications.

Authors:  W H Herman; R E Aubert; M M Engelgau; T J Thompson; M A Ali; E S Sous; M Hegazy; A Badran; S J Kenny; E W Gunter; A M Malarcher; R J Brechner; S F Wetterhall; F DeStefano; P J Smith; M Habib; S abd el Shakour; A S Ibrahim; E M el Behairy
Journal:  Diabet Med       Date:  1998-12       Impact factor: 4.359

2.  The clinical information value of the glycosylated hemoglobin assay.

Authors:  D M Nathan; D E Singer; K Hurxthal; J D Goodson
Journal:  N Engl J Med       Date:  1984-02-09       Impact factor: 91.245

3.  Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group.

Authors:  A Gray; M Raikou; A McGuire; P Fenn; R Stevens; C Cull; I Stratton; A Adler; R Holman; R Turner
Journal:  BMJ       Date:  2000-05-20

4.  Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections.

Authors:  H King; R E Aubert; W H Herman
Journal:  Diabetes Care       Date:  1998-09       Impact factor: 19.112

  4 in total
  15 in total

1.  Patient characteristics do not predict poor glycaemic control in type 2 diabetes patients treated in primary care.

Authors:  Alex N Goudswaard; Ronald P Stolk; Peter Zuithoff; Guy E H M Rutten
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

2.  Medication use and disease management of type 2 diabetes in Belgium.

Authors:  Els Mehuys; Leen De Bolle; Luc Van Bortel; Lieven Annemans; Inge Van Tongelen; Jean-Paul Remon; Mimi Giri
Journal:  Pharm World Sci       Date:  2007-06-23

3.  Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study.

Authors:  Michel Tiv; Jean-François Viel; Frédéric Mauny; Eveline Eschwège; Alain Weill; Cécile Fournier; Anne Fagot-Campagna; Alfred Penfornis
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

4.  ELSID-Diabetes study-evaluation of a large scale implementation of disease management programmes for patients with type 2 diabetes. Rationale, design and conduct--a study protocol [ISRCTN08471887].

Authors:  Stefanie Joos; Thomas Rosemann; Marc Heiderhoff; Michel Wensing; Sabine Ludt; Jochen Gensichen; Petra Kaufmann-Kolle; Joachim Szecsenyi
Journal:  BMC Public Health       Date:  2005-10-04       Impact factor: 3.295

5.  Prognostic value of physicians' assessment of compliance regarding all-cause mortality in patients with type 2 diabetes: primary care follow-up study.

Authors:  Dietrich Rothenbacher; Gernot Rüter; Hermann Brenner
Journal:  BMC Fam Pract       Date:  2006-07-07       Impact factor: 2.497

6.  Glycemic control among primary care patients with type 2 diabetes mellitus in the Gaza Strip, Palestine.

Authors:  Mahmoud Radwan; Aymen Elsous; Hasnaa Al-Sharif; Ayman Abu Mustafa
Journal:  Ther Adv Endocrinol Metab       Date:  2017-12-05       Impact factor: 3.565

7.  Factors affecting achievement of glycemic targets among type 2 diabetes patients in South Asia: Analysis of the CARRS trial.

Authors:  Muhammad Q Masood; Kavita Singh; Dimple Kondal; Mohammed K Ali; Minaz Mawani; Raji Devarajan; Usha Menon; Premlata Varthakavi; Vijay Viswanathan; Mala Dharmalingam; Ganapathi Bantwal; Rakesh Sahay; Rajesh Khadgawat; Ankush Desai; Dorairaj Prabhakaran; K M Venkat Narayan; Nikhil Tandon
Journal:  Diabetes Res Clin Pract       Date:  2020-11-24       Impact factor: 5.602

8.  Burden of Uncontrolled Hyperglycemia and Its Association with Patients Characteristics and Socioeconomic Status in Philadelphia, USA.

Authors:  Longjian Liu; Fengge Wang; Edward J Gracely; Kari Moore; Steven Melly; Fengqing Zhang; Priscila Y Sato; Howard J Eisen
Journal:  Health Equity       Date:  2020-12-30

9.  Prevalence and determinants of poor glycaemic control: a cross-sectional study among Moroccan type 2 diabetes patients.

Authors:  Ahmed Chetoui; Kamal Kaoutar; Soufiane Elmoussaoui; Kaltoum Boutahar; Abdesslam El Kardoudi; Fatiha Chigr; Mohamed Najimi
Journal:  Int Health       Date:  2020-01-20       Impact factor: 3.131

10.  National trends in the prevalence of glycemic control among patients with type 2 diabetes receiving continuous care in Thailand from 2011 to 2018.

Authors:  Boonsub Sakboonyarat; Warabhorn Pima; Channarong Chokbumrungsuk; Taksin Pimpak; Sirikorn Khunsri; Supak Ukritchon; Worarachanee Imjaijitt; Mathirut Mungthin; Wisit Kaewput; Bhophkrit Bhopdhornangkul; Nattapol Sathavarodom; Pyatat Tatsanavivat; Ram Rangsin
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.